Current Protein Identity:P12318 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1FCG ECTODOMAIN OF HUMAN FC GAMMA RECEPTOR, FCGRIIA Deposited 1999-04-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 34–207(174 aa) Fragment:EXTRACELLULAR DOMAINS
Mutation:S88F, R134H No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;HANGING DROP VAPOUR DIFFUSION WITH EQUAL VOLUMES OF FC(GAMMA)RIIA AT 6 MG/ML AND MOTHER LIQUOR (0.2 M AMMONIUM ACETATE, 30% W/V PEG 4000, 0.1 M SODIUM CITRATE PH 5.6) MIXED IN 3 MICRO L DROPLETS AND ALLOWED TO EQUILIBRATE AT 22 C FOR 3-9 DAYS.
Resolution 2.00 Å R-free 0.242
1H9V Human Fc-gamma-Receptor IIa (FcgRIIa), monoclinic Deposited 2001-03-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 37–208(172 aa) Fragment:IMMUNOGLOBULIN G BINDING DOMAIN RESIDUE 5-177
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5;0.2M NAOAC PH 4.6, 26% PEG 8000
Resolution 3.00 Å
3D5O Structural recognition and functional activation of FcrR by innate pentraxins Deposited 2008-05-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain F 37–207(171 aa)
Not recorded SO4 SULFATE ION × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;2.0 M NH4SO4, 5% iso-propanol, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.80 Å R-free 0.279
3RY4 1.5 Angstrom resolution structure of glycosylated fcgammariia (low-responder polymorphism) Deposited 2011-05-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 37–206(170 aa) Fragment:EXTRACELLULAR DOMAIN, residues 37-206
Mutation:S88P NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.6;30% (W/V) PEG 4000, 0.2M AMMONIUM ACETATE, 0.1M SODIUM CITRATE, PH 5.60, VAPOR DIFFUSION, TEMPERATURE 291.0K
Resolution 1.50 Å R-free 0.230
3RY5 Three-dimensional structure of glycosylated fcgammariia (high-responder polymorphism) Deposited 2011-05-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 37–206(170 aa) Fragment:EXTRACELLULAR DOMAIN, residues 114-327
Mutation:H134R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.5;30% (W/V) PEG 4000, 0.2M AMMONIUM SULFATE, PH 7.50, VAPOR DIFFUSION, TEMPERATURE 291.0K
Resolution 2.30 Å R-free 0.275
3RY6 Complex of fcgammariia (CD32) and the FC of human IGG1 Deposited 2011-05-11 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 40–206(167 aa) Fragment:UNP residues 40-206
Not recorded GOL GLYCEROL × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7.4;20% (W/V) PEG 3350, 5MM TRIS, 0.15M NACL, 2MM MOPS, 0.2M TRI-POTASSIUM ACETATE, PH 7.40, VAPOR DIFFUSION, TEMPERATURE 291.0K
Resolution 3.80 Å R-free 0.426
8CHA Fc gamma RIIa 27W/131H variant ectodomain Deposited 2023-02-07 Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–209(209 aa)
Mutation:Q27W FLC CITRATE ANION × 1 PO4 PHOSPHATE ION × 3 16P 3,6,9,12,15,18-HEXAOXAICOSANE × 1 PGE TRIETHYLENE GLYCOL × 1 DXE 1,2-DIMETHOXYETHANE × 1 FWN 2-[2-(2-ethoxyethoxy)ethoxy]ethanol × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.2;293.15 K;0.1M sodium phosphate citrate, pH4.2, 41% (v/v) PEG 300
Resolution 1.81 Å R-free 0.225
9MCX CRYSTAL STRUCTURE OF HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR IIA COMPLEX H131 VARIANT Deposited 2024-12-05 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 37–209(173 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;25% PEG 2000 MME, 0.1 M HEPES pH 7.5
Resolution 2.38 Å R-free 0.234
9N5P CRYSTAL STRUCTURE OF HUMAN IGG2 FC FRAGMENT-FC-GAMMA RECEPTOR IIA COMPLEX H131 VARIANT Deposited 2025-02-04 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 37–209(173 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;0.1 M HEPES pH 7.5, 25% PEG 2000 MME
Resolution 2.01 Å R-free 0.232